| Phenotypic analysis of antigen-specific T lymphocytes JD Altman, PAH Moss, PJR Goulder, DH Barouch, ... Science 274 (5284), 94-96, 1996 | 4733 | 1996 |
| Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection K Murali-Krishna, JD Altman, M Suresh, DJD Sourdive, AJ Zajac, JD Miller, ... Immunity 8 (2), 177-187, 1998 | 2440 | 1998 |
| Viral immune evasion due to persistence of activated T cells without effector function AJ Zajac, JN Blattman, K Murali-Krishna, DJD Sourdive, M Suresh, ... The Journal of experimental medicine 188 (12), 2205-2213, 1998 | 2412 | 1998 |
| Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine RR Amara, F Villinger, JD Altman, SL Lydy, SP O'Neil, SI Staprans, ... Science 292 (5514), 69-74, 2001 | 1446 | 2001 |
| Persistence of memory CD8 T cells in MHC class I-deficient mice K Murali-Krishna, LL Lau, S Sambhara, F Lemonnier, J Altman, R Ahmed Science 286 (5443), 1377-1381, 1999 | 977 | 1999 |
| Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia TM Allen, DH O'Connor, P Jing, JL Dzuris, BR Mothé, TU Vogel, ... Nature 407 (6802), 386-390, 2000 | 918 | 2000 |
| Estimating the precursor frequency of naive antigen-specific CD8 T cells JN Blattman, R Antia, DJD Sourdive, X Wang, SM Kaech, ... The Journal of experimental medicine 195 (5), 657-664, 2002 | 825 | 2002 |
| Virus-specific CD8+ T cells in primary and secondary influenza pneumonia KJ Flynn, GT Belz, JD Altman, R Ahmed, DL Woodland, PC Doherty Immunity 8 (6), 683-691, 1998 | 818 | 1998 |
| Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines JD Miller, RG van der Most, RS Akondy, JT Glidewell, S Albott, ... Immunity 28 (5), 710-722, 2008 | 669 | 2008 |
| Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b RE Vance, JR Kraft, JD Altman, PE Jensen, DH Raulet The Journal of experimental medicine 188 (10), 1841-1848, 1998 | 605 | 1998 |
| Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression H Radziewicz, CC Ibegbu, ML Fernandez, KA Workowski, K Obideen, ... Journal of virology 81 (6), 2545-2553, 2007 | 583 | 2007 |
| Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands JJ Boniface, JD Rabinowitz, C Wülfing, J Hampl, Z Reich, JD Altman, ... Immunity 9 (4), 459-466, 1998 | 450 | 1998 |
| Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells JM Grayson, AJ Zajac, JD Altman, R Ahmed The Journal of Immunology 164 (8), 3950-3954, 2000 | 437 | 2000 |
| IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection I Sereti, RM Dunham, J Spritzler, E Aga, MA Proschan, K Medvik, ... Blood, The Journal of the American Society of Hematology 113 (25), 6304-6314, 2009 | 411 | 2009 |
| Two roads diverged: interferon α/β–and interleukin 12–mediated pathways in promoting T cell interferon γ responses during viral infection LP Cousens, R Peterson, S Hsu, A Dorner, JD Altman, R Ahmed, ... The Journal of experimental medicine 189 (8), 1315-1328, 1999 | 390 | 1999 |
| Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors T Hanke, H Takizawa, CW McMahon, DH Busch, EG Pamer, JD Miller, ... Immunity 11 (1), 67-77, 1999 | 387 | 1999 |
| The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response RS Akondy, ND Monson, JD Miller, S Edupuganti, D Teuwen, H Wu, ... The Journal of Immunology 183 (12), 7919-7930, 2009 | 369 | 2009 |
| Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors JC Gea-Banacloche, SA Migueles, L Martino, WL Shupert, AC McNeil, ... The Journal of Immunology 165 (2), 1082-1092, 2000 | 347 | 2000 |
| Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART) CM Gray, J Lawrence, JM Schapiro, JD Altman, MA Winters, M Crompton, ... The journal of immunology 162 (3), 1780-1788, 1999 | 341 | 1999 |
| A Previously Unrecognized H-2Db-Restricted Peptide Prominent in the Primary Influenza A Virus-Specific CD8+T-Cell Response Is Much Less Apparent following … GT Belz, W Xie, JD Altman, PC Doherty Journal of virology 74 (8), 3486-3493, 2000 | 321 | 2000 |
